James Boiani, an Associate in the Health Care and Life Sciences practice, in the Washington, DC, office, and Stuart Gerson, a Member of the Firm in the Health Care and Life Sciences and Litigation practices, in the Washington, DC, office, co-wrote an article titled "Missing the Point (Of Care): FDA Misreading of CLIA Waiver Law Undermines Cost-Effective Health Testing."
Following is an excerpt:
The attached file is used with permission from the Washington Legal Foundation.